Nicotinic Receptor Antibody
From Anvita Health Wiki
Contents |
More Specific Terms
Indications
- evaluation of myasthenia gravis
Reference-interval
- < 0.03 nmol/L
Clinical-significance
- occurs in patients with myasthenia gravis ( MG).
- occasionally occur in association with:
- does NOT occur with congenital myasthenia gravis
- occurs in only 15% of patients with ocular myasthenia gravis
Methods
- False positives may occur with muscle relaxants:
- Acetylcholine receptor antibody is more sensitive for detection of MG than electromyography ( EMG) & is useful for following the response of MG to therapy. If negative & clinical suspicion of MG is high, acetylcholine receptor blocking & acetylcholine receptor modulating antibodies are used as 2nd & 3rd line tests.
Specimen
- serum
- store refrigerated or frozen without preservative
- do NOT use plasma
- stable at -20 degrees C
More General Terms
Additional Terms
- acetylcholine (nicotinic) receptor blocking antibody
- acetylcholine (nicotinic) receptor modulating antibody
- amyotrophic lateral sclerosis (ALS); Lou Gerig's disease
- Lambert-Eaton myasthenic syndrome (LEMS)
- myasthenia gravis
- nicotinic receptor (nicotinic acetylcholine receptor, nAChR)
- pernicious anemia
References
- Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 651
- Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995
